|
KIF24 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.9532999999985E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.79309999999555E-05 |
| Normal-vs-Stage2 |
7.92840000000128E-05 |
| Normal-vs-Stage3 |
1.00370000000183E-06 |
| Normal-vs-Stage4 |
1.243820E-01 |
| Stage1-vs-Stage2 |
1.738250E-01 |
| Stage1-vs-Stage3 |
6.256000E-02 |
| Stage1-vs-Stage4 |
4.963400E-01 |
| Stage2-vs-Stage3 |
9.701200E-01 |
| Stage2-vs-Stage4 |
1.704850E-01 |
| Stage3-vs-Stage4 |
1.348170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.586200E-04 |
| Normal-vs-AfricanAmerican |
1.6779799999922E-05 |
| Normal-vs-Asian |
9.168200E-01 |
| Caucasian-vs-AfricanAmerican |
1.140040E-01 |
| Caucasian-vs-Asian |
1.674410E-01 |
| AfricanAmerican-vs-Asian |
1.371790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.55585999999097E-05 |
| Normal-vs-Female |
6.174300E-04 |
| Male-vs-Female |
4.586400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.116700E-03 |
| Normal-vs-Age(41-60Yrs) |
2.763800E-03 |
| Normal-vs-Age(61-80Yrs) |
1.52519999996326E-06 |
| Normal-vs-Age(81-100Yrs) |
6.320100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.802030E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.489200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.872800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.088300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.447800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.850200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.788360E-01 |
| Normal-vs-Grade 2 |
4.35779999999886E-05 |
| Normal-vs-Grade 3 |
2.07580000000096E-05 |
| Normal-vs-Grade 4 |
3.525900E-02 |
| Grade 1-vs-Grade 2 |
5.292800E-01 |
| Grade 1-vs-Grade 3 |
4.457400E-01 |
| Grade 1-vs-Grade 4 |
5.402400E-01 |
| Grade 2-vs-Grade 3 |
6.939000E-01 |
| Grade 2-vs-Grade 4 |
9.575800E-01 |
| Grade 3-vs-Grade 4 |
9.228400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.080900E-03 |
| Normal-vs-ccB subtype |
4.25420000005339E-07 |
| ccA subtype-vs-ccB subtype |
1.680220E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.036200E-03 |
| Normal-vs-N1 |
9.269600E-01 |
| N0-vs-N1 |
2.101000E-01 |
|
|
